Oral
HTX - Immunosuppression, Therapeutics and Pharmacology
22 - Clinical Outcomes Associated With mTORi Initiation in Adult Heart Transplant: An ISHLT Registry Analysis
Presentation Number
22
Presenter
Co-Authors
- M. Alhussein, Toronto, ON, Canada
- S. Bhagra, Cambridge, United Kingdom
- A. Dipchand, Toronto, ON, Canada
- J. Duero Posada, Toronto, ON, Canada
- S. Fan, Toronto, ON, Canada
- C. Manlhiot, Toronto, ON, Canada
- Y. Moayedi, Palo Alto, CA, United States of America
- H. Ross, Toronto, ON, Canada
- J. Stehlik, Salt Lake City, UT, United States of America
Oral
MCS - Other
191 - Clinical Outcomes with Heartmate 3TM Left Ventricular Assist Device as Treatment for Advanced Heart Failure: 12-Month Outcomes from the ELEVATE Registry
Presentation Number
191
Presenter
Co-Authors
- F. Beyersdorf, Freiburg, Germany
- L. Damme, Chicago, IL, United States of America
- J. Garbade, Leipzig, Germany
- F. Gustafsson, Copenhagen, Denmark
- J. Lavee, Tel Aviv, Israel
- S. Lim, Birmingham, United Kingdom
- M. Morshuis, Bad Oeynhausen, Germany
- D. Saeed, Düsseldorf, Germany
- S. Shaw, Manchester, United Kingdom
- D. Zimpfer, Vienna, Austria
Oral
LTX - Immunosuppression, Therapeutics and Pharmacology
484 - Consequences of Delayed Chest Closure During Lung Transplantation
Presentation Number
484
Co-Authors
- U. Ahmad, Cleveland, OH, United States of America
- E. Blackstone, Cleveland, OH, United States of America
- M. Budev, Cleveland, OH, United States of America
- H. Hassouna, Cleveland, OH, United States of America
- M. Ibrahim, Cleveland, OH, United States of America
- D. Johnston, Cleveland, OH, United States of America
- C. Koval, Cleveland, OH, United States of America
- K. McCurry, Cleveland, OH, United States of America
- G. Pettersson, Cleveland, OH, United States of America
- S. Rafiroiu, Cleveland, OH, United States of America
- M. Tong, Cleveland, OH, United States of America
- A. Toth, Cleveland, OH, United States of America
Oral
ID - Heart
376 - Defining Severe Secondary Antibody Deficiency in Heart and Lung Transplantation
Presentation Number
376
Presenter
Co-Authors
- L. Almenar, Valencia, Spain
- C. Bravo, Barcelona, Spain
- J. Carbone, Madrid, Spain
- J. Cifrian, Santander, Spain
- M. Crespo-Leiro, A Coruña, Spain
- A. De Pablos, Madrid, Spain
- M. Gomez-Sanchez, Madrid, Spain
- R. Laporta, Madrid, Spain
- J. Lopez, Valladolid, Spain
- S. Mirabet, Barcelona, Spain
- J. Navarro, Madrid, Spain
- G. Rabago, Navarra, Spain
- E. Sarmiento, Madrid, Spain
- J. Segovia, Madrid, Spain
- A. Sole, Valencia, Spain
- I. Sousa, Madrid, Spain
Oral
MCS - Complications Bleeding/Thrombosis
Mini Oral
HTX - Primary Graft Dysfunction
246 - Discontinuing Amiodarone Treatment Prior to Heart Transplant May Lower Incidence of Severe Primary Graft Dysfunction
Presentation Number
246
Co-Authors
- P. Colombo, New York City, NY, United States of America
- M. Farr, New York, NY, United States of America
- J. Han, New York, NY, United States of America
- B. Hoemann, New York City, NY, United States of America
- D. Jennings, New York City, NY, United States of America
- Y. Naka, New York, NY, United States of America
- S. Restaino, New York, NY, United States of America
- H. Takayama, New York, NY, United States of America
- K. Takeda, New York, NY, United States of America
- M. Wright, New York City, NY, United States of America
Oral
BSTR - Immunology, Inflammation, Immunosuppression
496 - Distinct Phenotypic, Molecular and Immune Characteristics of Circulating Exosomes From Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome versus Stable Patients
Presentation Number
496
Co-Authors
- R. Bremner, Phoenix, AZ, United States of America
- S. Elnahas, Phoenix, AZ, United States of America
- M. Gunasekaran, Phoenix, AZ, United States of America
- R. Hachem, Phoenix, AZ, United States of America
- T. Mohanakumar, Phoenix, AZ, United States of America
- F. Rodriguez, Phoenix, AZ, United States of America
- M. Sharma, Phoenix, AZ, United States of America
- M. Smith, Phoenix, AZ, United States of America
- R. Walia, Phoenix, AZ, United States of America
Mini Oral
LTX - Infectious Diseases
264 - Donor Derived Cell Free DNA is Elevated With Pathogens That are Risk Factors For Chronic Lung Allograft Dysfunction
Presentation Number
264
Co-Authors
- S. Agbor-Enoh, Baltimore, MD, United States of America
- R. Avery, Baltimore, MD, United States of America
- A. Brown, Fairfax, VA, United States of America
- A. Gandhi, Baltimore, MD, United States of America
- A. Iacono, Baltimore, MD, United States of America
- A. Joshi, Baltimore, MD, United States of America
- N. Kim, Baltimore, MD, United States of America
- S. Nathan, Fairfax, MD, United States of America
- M. Nayyar, Charlottesville, VA, United States of America
- J. Orens, Baltimore, MD, United States of America
- M. Rohly, Athens, GA, United States of America
- P. Shah, Baltimore, MD, United States of America
- I. Timofte, Baltimore, MD, United States of America
- H. Valantine, Baltimore, VA, United States of America
Mini Oral
NHSAH - Nursing
Mini Oral
PH - Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Oral
LTX - Clinical Ex-Vivo Lung Perfusion and Preservation
358 - Ex-vivo Lung Perfusion - 10 Year Follow-up of the First Performed Double LTX With Marginal Donor Lungs Evaluated Using EVLP
Presentation Number
358
Presenter
Oral
LTX - Chronic Lung Allograft Dysfunction
62 - Exosomes With Lung Self-antigens, Kα1Tubulin and Collagen V, as Biomarker for Bronchiolitis Obliterans Syndrome Following Human Lung Transplantation
Presentation Number
62
Co-Authors
- S. Biswas Roy, Phoenix, AZ, United States of America
- R. Bremner, Phoenix, AZ, United States of America
- S. Elnahas, Phoenix, AZ, United States of America
- M. Gunasekaran, Phoenix, AZ, United States of America
- R. Hachem, Phoenix, AZ, United States of America
- T. Mohanakumar, Phoenix, AZ, United States of America
- M. Sharma, Phoenix, AZ, United States of America
- M. Smith, Phoenix, AZ, United States of America